{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T04:44:36Z","timestamp":1693197876631},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00105-019-4432-6","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:37:47Z","timestamp":1559126267000},"page":"490-496","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heredit\u00e4re Hauttumorsyndrome"],"prefix":"10.1007","volume":"70","author":[{"given":"M. A.","family":"Hermasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"4432_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1684\/ejd.2009.0749","volume":"19","author":"S Badeloe","year":"2009","unstructured":"Badeloe S, Frank J (2009) Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis. Eur J Dermatol 19:545\u2013551","journal-title":"Eur J Dermatol"},{"key":"4432_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/nm.4368","volume":"23","author":"E Bal","year":"2017","unstructured":"Bal E, Park HS, Belaid-Choucair Z et al (2017) Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas. Nat Med 23:1226\u20131233","journal-title":"Nat Med"},{"key":"4432_CR3","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.3107130","volume":"236","author":"D Barker","year":"1987","unstructured":"Barker D, Wright E, Nguyen K et\u00a0al (1987) Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 236:1100\u20131102","journal-title":"Science"},{"key":"4432_CR4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1159\/000055853","volume":"1","author":"DK Bartsch","year":"2001","unstructured":"Bartsch DK, Sina-Frey M, Ziegler A et al (2001) Update of familial pancreatic cancer in Germany. Pancreatology 1:510\u2013516","journal-title":"Pancreatology"},{"key":"4432_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/76006","volume":"25","author":"GR Bignell","year":"2000","unstructured":"Bignell GR, Warren W, Seal S et al (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 25:160\u2013165","journal-title":"Nat Genet"},{"key":"4432_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00292-014-1934-y","volume":"35","author":"A Boer-Auer","year":"2014","unstructured":"Boer-Auer A (2014) Differential diagnostics of sebaceous tumors. Pathologe 35:443\u2013455","journal-title":"Pathologe"},{"key":"4432_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/ng.780","volume":"43","author":"DR Goudie","year":"2011","unstructured":"Goudie DR, D\u2019alessandro M, Merriman B et al (2011) Multiple self-healing squamous epithelioma is caused by a\u00a0disease-specific spectrum of mutations in TGFBR1. Nat Genet 43:365\u2013369","journal-title":"Nat Genet"},{"key":"4432_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.jid.2018.01.015","volume":"138","author":"C Gunther","year":"2018","unstructured":"Gunther C, Lee-Kirsch MA, Eckhard J et al (2018) SMARCAD1 Haploinsufficiency underlies Huriez syndrome and associated skin cancer susceptibility. J\u00a0Invest Dermatol 138:1428\u20131431","journal-title":"J Invest Dermatol"},{"key":"4432_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00105-013-2715-x","volume":"65","author":"L Hubinger","year":"2014","unstructured":"Hubinger L, Frank J (2014) Genodermatoses with malignant skin tumors. Hautarzt 65:527\u2013535","journal-title":"Hautarzt"},{"key":"4432_CR10","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.272.5268.1668","volume":"272","author":"RL Johnson","year":"1996","unstructured":"Johnson RL, Rothman AL, Xie J et\u00a0al (1996) Human homolog of patched, a\u00a0candidate gene for the basal cell nevus syndrome. Science 272:1668\u20131671","journal-title":"Science"},{"key":"4432_CR11","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/hmg\/4.8.1471","volume":"4","author":"A Kumar","year":"1995","unstructured":"Kumar A, Wolpert C, Kandt RS et al (1995) A de novo frame-shift mutation in the tuberin gene. Hum Mol Genet 4:1471\u20131472","journal-title":"Hum Mol Genet"},{"key":"4432_CR12","first-page":"1159","volume":"38","author":"J Lehmann","year":"2018","unstructured":"Lehmann J, Seebode C, Martens MC et\u00a0al (2018) Xeroderma Pigmentosum\u2014facts and perspectives. Anticancer Res 38:1159\u20131164","journal-title":"Anticancer Res"},{"key":"4432_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ng0597-64","volume":"16","author":"D Liaw","year":"1997","unstructured":"Liaw D, Marsh DJ, Li J et\u00a0al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64\u201367","journal-title":"Nat Genet"},{"key":"4432_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S1470-2045(09)70188-3","volume":"10","author":"FH Menko","year":"2009","unstructured":"Menko FH, Van Steensel MA, Giraud S et al (2009) Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol 10:1199\u20131206","journal-title":"Lancet Oncol"},{"key":"4432_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2133.2011.10219.x","volume":"165","author":"LJ Parren","year":"2011","unstructured":"Parren LJ, Abuzahra F, Wagenvoort T et al (2011) Linkage refinement of Bazex-Dupre-Christol syndrome to an 11.4-Mb interval on chromosome Xq25-27.1. Br J Dermatol 165:201\u2013203","journal-title":"Br J Dermatol"},{"key":"4432_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/ijd.12199","volume":"53","author":"LJ Parren","year":"2014","unstructured":"Parren LJ, Ferdinandus P, Van Der Hulst R et\u00a0al (2014) A novel therapeutic strategy for turban tumor: scalp excision and combined reconstruction with artificial dermis and split skin graft. Int J Dermatol 53:246\u2013249","journal-title":"Int J Dermatol"},{"key":"4432_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1046\/j.1523-1747.2002.01839.x","volume":"119","author":"P Poblete Gutierrez","year":"2002","unstructured":"Poblete Gutierrez P, Eggermann T, Holler D et\u00a0al (2002) Phenotype diversity in familial cylindromatosis: a\u00a0frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. J\u00a0Invest Dermatol 119:527\u2013531","journal-title":"J Invest Dermatol"},{"key":"4432_CR18","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S1470-2045(05)70465-4","volume":"6","author":"G Ponti","year":"2005","unstructured":"Ponti G, Ponz De Leon M (2005) Muir-Torre syndrome. Lancet Oncol 6:980\u2013987","journal-title":"Lancet Oncol"},{"key":"4432_CR19","first-page":"272","volume":"43","author":"E Rieger","year":"1992","unstructured":"Rieger E, Kerl H (1992) The clinical spectrum of organ manifestations of tuberous sclerosis. Hautarzt 43:272\u2013277","journal-title":"Hautarzt"},{"key":"4432_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","volume":"79","author":"DL Smit","year":"2011","unstructured":"Smit DL, Mensenkamp AR, Badeloe S et\u00a0al (2011) Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet 79:49\u201359","journal-title":"Clin Genet"},{"issue":"259","key":"4432_CR21","first-page":"e251","volume":"66","author":"TM Starink","year":"2012","unstructured":"Starink TM, Houweling AC, Van Doorn MB et al (2012) Familial multiple discoid fibromas: a\u00a0look-alike of Birt-Hogg-Dube syndrome not linked to the FLCN locus. J\u00a0Am Acad Dermatol 66(259):e251\u2013e259","journal-title":"J Am Acad Dermatol"},{"key":"4432_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M Van Slegtenhorst","year":"1997","unstructured":"Van Slegtenhorst M, De Hoogt R, Hermans C et\u00a0al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805\u2013808","journal-title":"Science"},{"key":"4432_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00667.x","volume":"70","author":"AL Young","year":"2006","unstructured":"Young AL, Kellermayer R, Szigeti R et al (2006) CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes. Clin Genet 70:246\u2013249","journal-title":"Clin Genet"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-019-4432-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-019-4432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:40:51Z","timestamp":1590622851000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-019-4432-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1007\/s00105-019-4432-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"29 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.A.\u00a0Hermasch erkl\u00e4rt, dass er sich bei der Erstellung des Beitrags nicht von wirtschaftlichen Interessen leiten lie\u00df und er keine Interessenkonflikte hat. J.\u00a0Frank erkl\u00e4rt, dass er sich bei der Erstellung des Beitrags nicht von wirtschaftlichen Interessen leiten lie\u00df. Er legt folgende m\u00f6gliche Interessenkonflikte offen: Er hat von den Firmen Genzyme und Shire Vortragshonorare und eine finanzielle Unterst\u00fctzung f\u00fcr den 2.\u00a0Weltkongress f\u00fcr Genodermatologie im Jahr 2011 in Maastricht, Niederlande, erhalten. Er hat von den Firmen Roche, Bristol-Myers Squibb, Novartis, MSD und Orphan Europe Germany GmbH Vortragshonorare und finanzielle Unterst\u00fctzung zur Durchf\u00fchrung von Fortbildungsveranstaltungen erhalten. Dar\u00fcber hinaus hat er von der Firma Clinuvel eine Reisekostenunterst\u00fctzung zur Teilnahme am 23.\u00a0Weltkongress f\u00fcr Dermatologie in Vancouver, Kanada, erhalten und war als Studienleiter an 2 klinischen Studien der Phase\u00a0II und III der Firma Clinuvel beteiligt. Ferner hat er f\u00fcr die Organisation und Durchf\u00fchrung des Weltkongresses f\u00fcr Porphyrie-Erkrankungen 2015 (International Congress on Porphyrins and Porphyrias 2015) eine finanzielle Unterst\u00fctzung von den Firmen Alnylam Pharmaceuticals, Orphan Europe, Clinuvel Pharmaceuticals, La Roche-Posay und Lilly Deutschland GmbH erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}